Global vaccine program COVAX low on funds, seeks $5.2B
PTI, Jan 20, 2022, 8:06 AM IST
Representative Image
Geneva: The global initiative to share coronavirus vaccines equally between rich and poor countries asked Wednesday for USD 5.2 billion in funds to be able to keep buying doses in the coming months.
The UN-backed programme known as COVAX has delivered just over 1 billion doses since shipments started nearly a year ago.
The initial goal was to deliver 2 billion doses by the end of 2021, but COVAX’s lack of cash when vaccine deals were being made gave it a late start, and most of the world’s vaccine doses have gone to wealthy nations who locked-in contracts.
As things stand now, less than 10 percent of the people in low-income countries have received at least one dose, while more than 60 percent of the world’s overall population has been vaccinated — some with three or four doses.
Seth Berkley, the CEO of GAVI, the global health organization that co-founded the COVAX initiative, said it was key to supplying poor countries with vaccine shots now and in the future but “we right now are basically out of money.”
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
COP29: India rejects new USD 300 billion climate finance deal
Royal tour of India in offing for King Charles, Queen Camilla: Report
Indian-American leaders applaud PM Modi for inclusive growth in India
COP29: Civil society protests climate finance proposal, calls for ‘no deal’ over ‘bad deal’
Bomb disposal squad tackles ‘security incident’ at UK’s Gatwick Airport
MUST WATCH
Latest Additions
Wanted to kill Ajmal Kasab who caused so much of pain, recalls 26/11 terror attack victim
Two retired revenue officials among four arrested in land grabbing case in Jammu
Kerala govt to revise manual for junior doctors, house surgeons
State can interfere with religious practices if they impede development, equality rights: SC
Four cheers at MP’s Kuno park; cheetah Neerva gives birth to cub quartet
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.